Structural insights into target detection by the S. marcescens type III CRISPR complex and its deployment inSNP identification
Calvin PerdigaoiD, Luqman O. Ajisafe, Anju Teresa Sunny, Si WuiD, Terje DoklandiD, J.A. DunkleiD
Abstract
Type III CRISPR systems utilize a complex containing Cas10, additional Cas proteins and a crRNA to detect foreign transcripts. Upon detection, Cas10 synthesizes cyclic oligoadenylates (cOA), signaling molecules that coordinate interference by stimulating downstream enzymes with DNase, RNase, protease or other activities. Type III systems are among the most abundant CRISPR systems in prokaryotes and understanding the structure-function relationships that control transcript detection and cOA synthesis will advance the understanding of the broader physiological roles of these systems. Type III systems possess properties well-suited to their deployment as molecule diagnostics: specific detection and activation of a cascade of multi-turnover enzymatic reactions that can be harnessed for signal generation. We determined that Serratia marcescens Cas10-Csm (SmCas10-Csm) synthesizes predominantly cA3 molecules and this synthesis is sensitive to mismatches in the crRNA-target RNA duplex adjacent to Cas10. We determined the structure of SmCas10-Csm unbound and bound to target RNA identifying conformational changes associated with target binding. We demonstrate that SmCas10-Csm can distinguish between single nucleotide polymorphisms that occur in the human HBB transcript that are associated with sickle cell disease indicating an additional role for type III CRISPR systems in point-of-care diagnostics in low-resource settings.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 1
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- SCOPE: Flexible targeting and stringent CARF activation enables type III CRISPR-Cas diagnostics
J. A. Steens, Y. Zhu, … R. H. J. Staals·Nature CommunicationsPeer-reviewed·Aug 19, 2021
- The structure of a Type III-A CRISPR-Cas effector complex reveals conserved and idiosyncratic contacts to target RNA and crRNA among Type III-A systems
Mohammadreza Paraan, Mohamed Nasef, … J.A. Dunkle·PLoS ONEPeer-reviewed·Jun 23, 2023
- Structure of the Saccharolobus solfataricus type III-D CRISPR effector
L. Spagnolo, M. White, … S. Graham·bioRxiv·Nov 14, 2022
- Cas10 residues lining the target RNA binding channel regulate interference by distinguishing cognate target RNA from mismatched targets
Sarah A. Khweis, Mason Blackburn, … J.A. Dunkle·RNA BiologyPeer-reviewed·Feb 18, 2026
- Specificity and sensitivity of an RNA targeting type III CRISPR complex coupled with a NucC endonuclease effector
S. Gruschow, C. S. Adamson, M. F. White·bioRxiv·Sep 13, 2021
- Type III CRISPR-Cas systems generate cyclic oligoadenylate second messengers to activate Csm6 RNases
O. Niewoehner, C. Garcia-Doval, … M. Jinek·bioRxiv·Jun 23, 2017